Financials Bridgepoint Group plc

Equities

Real-time Estimate Cboe Europe Other stock markets 03:26:12 2024-12-06 am EST			5-day change	1st Jan Change
356.20 ^GBX	+0.06%		+2.89%	+27.44%

Dec. 02	Esker: takeover bid opens on Monday	CF
Nov. 11	Bridgepoint Europe VII, a fund managed by Bridgepoint Advisers Limited and Bridgepoint Group plc agreed to acquire an unknown majority stake in Schuberg Philis B.V.	CI

Fiscal Period: December	2021	2022	2023	2024	2025	2026
Net sales ¹	270.6	307.4	321.6	478.2	532.4	600.6
Change	-	13.6%	4.62%	48.69%	11.33%	12.83%
EBITDA ¹	113.9	140.3	148.8	249.4	271.3	332.3
Change	-	23.18%	6.06%	67.64%	8.76%	22.48%
EBIT ¹	102	125	133.1	225.6	249.9	308
Change	-	22.55%	6.48%	69.53%	10.75%	23.25%
Interest Paid ¹	-7.7	-4.7	-9.1	-11.7	-26.87	-27.87
Earnings before Tax (EBT) ¹	62.6	127.4	86	210.4	219.8	245.6
Change	-	103.51%	-32.5%	144.62%	4.47%	11.73%
Net income ¹	57.8	120.6	70.7	174	183.7	224.7
Change	-	108.65%	-41.38%	146.11%	5.6%	22.26%
Announcement Date	3/24/22	3/16/23	3/14/24	-	-	-

¹GBP in Million

Estimates

Fiscal Period: December	2022 S1	2022 S2	2023 S1	2023 S2	2024 S1
Net sales	-	167.3	137.8	-	-
Change	-	-	-17.63%	-100%	-
EBITDA	-	78.5	55.6	-	-
Change	-	-	-29.17%	-100%	-
EBIT	-	70.8	52.4	84.6	-
Change	-	-	-25.99%	61.45%	-100%
Charge d'intérêts	-	-	-	-5.6	-
Earnings before Tax (EBT) ¹	-	79.1	53.1	-	48.8
Change	-	-	-32.87%	-100%	-
Net income ¹	44.9	75.7	48.2	22.5	43.1
Change	-	68.6%	-36.33%	-53.32%	91.56%
Announcement Date	7/26/22	3/16/23	7/25/23	3/14/24	7/19/24

¹GBP in Million

Estimates

Fiscal Period: December	2021	2022	2023	2024	2025	2026
Net Debt ¹	-238	-	-157	190	195	129
Change	-	-	-	20.87%	2.63%	-33.85%
Announcement Date	3/24/22	3/16/23	3/14/24	-	-	-

¹GBP in Million

Estimates

Fiscal Period: December	2021	2022	2023	2024	2025	2026
CAPEX ¹	6.3	22.6	4	11.5	11.5	11.5
Change	-	258.73%	-82.3%	187.5%	0%	0%
Free Cash Flow (FCF) ¹	-	11.3	143.8	176.6	172.9	208.5
Change	-	-	1,172.57%	22.84%	-2.12%	20.59%
Announcement Date	3/24/22	3/16/23	3/14/24	-	-	-

¹GBP in Million

Estimates

Fiscal Period: December	2021	2022	2023	2024	2025	2026
Profitability
EBITDA Margin (%)	42.09%	45.64%	46.27%	52.16%	50.96%	55.32%
EBIT Margin (%)	37.69%	40.66%	41.39%	47.19%	46.94%	51.28%
EBT Margin (%)	23.13%	41.44%	26.74%	43.99%	41.28%	40.88%
Net margin (%)	21.36%	39.23%	21.98%	36.39%	34.52%	37.4%
FCF margin (%)	-	3.68%	44.71%	36.94%	32.48%	34.71%
FCF / Net Income (%)	-	9.37%	203.39%	101.52%	94.1%	92.81%
Profitability
ROA	4.97%	-	5.69%	4.63%	3.7%	5.11%
ROE	11.28%	15.2%	15.86%	17.88%	14.85%	16.98%
Financial Health
Leverage (Debt/EBITDA)	-	-	-	0.76x	0.72x	0.39x
Debt / Free cash flow	-	-	-	1.07x	1.13x	0.62x
Capital Intensity
CAPEX / Current Assets (%)	2.33%	7.35%	1.24%	2.4%	2.16%	1.91%
CAPEX / EBITDA (%)	5.53%	16.11%	2.69%	4.61%	4.24%	3.46%
CAPEX / FCF (%)	-	200%	2.78%	6.51%	6.65%	5.52%
Items per share
Cash flow per share ¹	0.0649	0.0412	0.186	0.1978	0.2172	0.266
Change	-	-36.54%	351.68%	6.34%	9.81%	22.47%
Dividend per Share ¹	0.0364	0.04	0.044	0.0926	0.1019	0.1132
Change	-	9.89%	10%	110.43%	10.06%	11.05%
Book Value Per Share ¹	0.8701	0.9396	0.9078	1.155	1.238	1.366
Change	-	7.99%	-3.38%	27.19%	7.2%	10.32%
EPS ¹	0.0702	0.1464	0.087	0.1737	0.1801	0.2172
Change	-	108.55%	-40.57%	99.68%	3.69%	20.56%
Nbr of stocks (in thousands)	823,269	823,269	794,027	822,642	822,642	822,642
Announcement Date	3/24/22	3/16/23	3/14/24	-	-	-